✦ LIBER ✦

Mechanism of T lymphocyte activation by OKT3 antibodies. A general model for T cell induction

✍ Scribed by Ulf Landegren; Jan Andersson; Hans Wigzell

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 429 KB
Volume: 14
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.1830140409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retargeting of T-cell-receptor gamma/del

Retargeting of T-cell-receptor gamma/delta+ lymphocytes against tumor cells by bispecific monoclonal antibodies. Induction of cytolytic activity and lymphokine production

✍ Silvano Ferrini; Ignazia Prigione; Serafina Mammoliti; Maria Ines Colnaghi; Sylv 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 307 KB

We have recently selected MAbs specific for different molecular forms of the TCR gammddelta (expressed by distinct cell subsets), able to activate TCR gamma/delta+ cells. Two of these reagents (GI and Al3) were used for the construction of bispecific MAbs in conjunction with a MAb (Mov 19) directed

Anti-CD3-based bispecific antibody desig

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies

NKG2A is a marker for acquisition of reg

NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody

✍ Vitaly Ablamunits; Octavian Henegariu; Paula Preston-Hurlburt; Kevan C. Herold 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 1 views

## Abstract Treatment with anti‐CD3 mAb modulates immune responses that cause type 1 diabetes and other diseases. CD8^+^ Tregs can be induced in vitro and in vivo by mAb. However, 1/3 of patients do not respond to drug therapy and in an equal proportion, anti‐CD3 mAb does not induce Tregs in vitro.

Induction of p202, a modulator of apopto

Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival

✍ Hong Xin; Yanbiao Geng; Rocky Pramanik; Divaker Choubey 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

## Abstract Previous studies have revealed that p202 (52 kDa), an interferon (IFN) and differentiation‐inducible protein, negatively regulates cell proliferation and modulates cell survival. However, the role of p202 in transformed cells remains to be investigated. Here we report that constitutive

Local immunotherapy of glioma patients w

Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situ T-cell activation and therapeutic efficacy

✍ Gundram Jung; Martina Brandl; Wilhelm Eisner; Peter Fraunberger; Guido Reifenber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB 👁 2 views

Generalized autoimmunity of the nervous

Generalized autoimmunity of the nervous system (GANS) induced by a recombinant protein composed of major pathogenic determinants of MBP, IRBP, and P2 protein: Suppression of inflammation by a monoclonal antibody against activated rat T line cells

✍ H. Schluesener 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

We have developed a new model of generalized autoimmunity of the rat nervous system to study differential immunoregulation, barrier-function, and parenchymal inflammatory processes. We designed a mul ticomponen t synthetic gene encoding major pathogenic determinants for Lewis rats of myelin basic pr